Clinical Trials Directory

Trials / Unknown

UnknownNCT03710616

A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals

A Real-world Study to Explore Recurrence/Metastases of the Early-stage (I-IIIA) NSCLC Patients and the Impact Factors of Patient Survivals

Status
Unknown
Phase
Study type
Observational
Enrollment
700 (estimated)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The real-world study was designed to explore recurrence/metastases of the patients with non-small cell lung cancer as measured by patient survivals and the impact factors of patient survivals.

Detailed description

The trial was designed as a real-world observational study to recruit those patients with pathologically diagnosed early-phase non-small cell lung cancer (NSCLC) who were enrolled in the clinical form 2009 to 2017 and explore recurrence/metastases of the NSCLC patients as measured by patient survivals and the impact factors of patient survivals. The study data on patient demographic characteristics, tumor biological characteristics, and clinicla treatments were collected via a retrospectively review method for evaluation of patient survivals and the relevance of clinical characteristics of the patients and patient survivals.

Conditions

Interventions

TypeNameDescription
PROCEDURESurgeriesSurgical operations plus systematic lymphadenectomies

Timeline

Start date
2018-03-24
Primary completion
2022-12-30
Completion
2023-01-01
First posted
2018-10-18
Last updated
2019-08-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03710616. Inclusion in this directory is not an endorsement.

A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals (NCT03710616) · Clinical Trials Directory